The prognostic value of the neutrophil-lymphocyte ratio in renal oncology: A review - Aix-Marseille Université Access content directly
Journal Articles Urologic Oncology: Seminars and Original Investigations Year : 2017

The prognostic value of the neutrophil-lymphocyte ratio in renal oncology: A review

Abstract

The neutrophils/lymphocytes ratio (NLR) is a biological marker of inflammation with a demonstrated prognostic value in the field of oncology. In this review we discussed the prognostic value of the NLR in renal cell carcinomas (RCC), where several multiparametric nomograms already existed. For localized RCC, a NLR <3 was predictive of a reduced risk of recurrence. In metastatic or locally advanced RCC, a NLR <3 predicted an increased overall survival, progression-free survivals and response to systemic treatment. In current practice the NLR is a simple costless prognostic factor with potential improvement in the prognostic performance of nomograms used in renal oncology.
Fichier principal
Vignette du fichier
The prognostic value.pdf (563.29 Ko) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-01792761 , version 1 (22-05-2018)

Identifiers

Cite

Romain Boissier, Jennifer Campagna, Nicolas Branger, Gilles Karsenty, Eric Lechevallier. The prognostic value of the neutrophil-lymphocyte ratio in renal oncology: A review. Urologic Oncology: Seminars and Original Investigations, 2017, pp.135 - 141. ⟨10.1016/j.urolonc.2017.01.016⟩. ⟨hal-01792761⟩

Collections

CNRS UNIV-AMU CRCM
121 View
415 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More